Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances A Shepherd

Showing results (1-10 of 384) with videos related to

Pageof 39
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2008
Molecular selection of patients for first-line treatment of advanced non-small-cell lung cancer with epidermal growth factor inhibitors: not quite ready for prime timeFrances A Shepherd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2011
Molecular selection trumps clinical selectionFrances A Shepherd
Seminars in Oncology|February 7, 2003
Pemetrexed in the treatment of non-small cell lung cancerFrances A Shepherd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2005
A targeted approach to reducing lung cancer mortalityFrances A Shepherd
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
Second-line chemotherapy for non-small cell lung cancer: is more better or just simply more?Frances A Shepherd
Oncology (Williston Park, N.Y.)|September 2, 2004
Current paradigms in first-line treatment of non-small-cell lung cancerFrances A Shepherd
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Should EGFR tyrosine kinase inhibitors be used in non-small cell lung cancer in the absence of EGFR mutations? Yes, there is a role for EGFR TKIs in these patientsFrances A Shepherd
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 27, 2010
Surgery for limited stage small cell lung cancer: time to fish or cut baitFrances A Shepherd
Expert Review of Anticancer Therapy|August 26, 2003
Second-line chemotherapy for non-small cell lung cancerFrances A Shepherd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Maintenance therapy comes of age for non-small-cell lung cancer, but at what cost?Frances A Shepherd
Pageof 39

Showing results (1-10 of 384) with videos related to

Sort By:
Pageof 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2008
Molecular selection of patients for first-line treatment of advanced non-small-cell lung cancer with epidermal growth factor inhibitors: not quite ready for prime timeFrances A Shepherd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2011
Molecular selection trumps clinical selectionFrances A Shepherd
Seminars in Oncology|February 7, 2003
Pemetrexed in the treatment of non-small cell lung cancerFrances A Shepherd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2005
A targeted approach to reducing lung cancer mortalityFrances A Shepherd
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
Second-line chemotherapy for non-small cell lung cancer: is more better or just simply more?Frances A Shepherd
Oncology (Williston Park, N.Y.)|September 2, 2004
Current paradigms in first-line treatment of non-small-cell lung cancerFrances A Shepherd
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Should EGFR tyrosine kinase inhibitors be used in non-small cell lung cancer in the absence of EGFR mutations? Yes, there is a role for EGFR TKIs in these patientsFrances A Shepherd
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 27, 2010
Surgery for limited stage small cell lung cancer: time to fish or cut baitFrances A Shepherd
Expert Review of Anticancer Therapy|August 26, 2003
Second-line chemotherapy for non-small cell lung cancerFrances A Shepherd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Maintenance therapy comes of age for non-small-cell lung cancer, but at what cost?Frances A Shepherd
Pageof 39